XML 49 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 7 - Stockholders' Equity: (Tables)
6 Months Ended
Dec. 31, 2012
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
average,
December 31,
2012
Range,
December 31,
2012
 
Weighted
average,
December 31,
2011
Range,
December 31,
2011
Volatility
 
66%
60%
-
68%  
84%
61%
-
88%
Dividend yield
 
-
 
-
   
-
 
-
 
Risk-free interest rate
 
0.32%
0.31%
-
0.34%  
1.37%
0.25%
-
2.02%
Expected term (years)
 
3.05
2.66
-
3.25  
4.1
2
-
4.5
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2012
    5,111,145       2.86       4.6       274,200  
Granted
    150,000       2.10                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
Outstanding at December 31, 2012
    5,261,145     $ 2.84       4.1     $ 113,750  
Exercisable at December 31, 2012
    4,671,145     $ 2.85       4.0     $ 113,750  
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted
Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2012
    590,000     $ 1.83  
Granted
    150,000       0.83  
Vested
    (150,000 )     (0.83 )
Forfeited
    -       -  
Nonvested at December 31, 2012
    590,000     $ 1.83  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
December 31,
2012
   
Three
months
ended
December 31,
2011
   
Six months
ended
December 31,
2012
   
Six months
ended
December 31,
2011
 
General and administrative:
                       
Fair value of stock/warrant bonuses expensed
  $ -     $ -     $ 1,151,250     $ 1,035,300  
Fair value of stock issued to an employee
    24,999       24,999       49,998       49,998  
Change in fair value from modification of option terms
    -       -       -       94,820  
Fair value of stock options expensed
    104,732       319,422       335,085       2,165,688  
Total
  $ 129,731     $ 344,421     $ 1,536,333     $ 3,345,806  
                                 
Research and development:
                               
Fair value of stock options expensed
  $ 9,323     $ -     $ 18,025     $ 40,598  
Total
  $ 9,323     $ -     $ 18,025     $ 40,598